Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Susanna V. Ulahannan et al.|Journal of Hepatology|2016Cited by 817
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple MyelomaNeha Korde, Ola Landgren, Maryalice Stetler‐Stevenson et al.|JAMA Oncology|2015Cited by 309
2‐Methoxyestradiol, a Promising Anticancer AgentNehal J. Lakhani, William D. Figg, Mohamadi Sarkar et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003Cited by 276
Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade GliomasHoward A. Fine, Craig B. Borkowf, Patrick Y. Wen et al.|Journal of Clinical Oncology|2003Cited by 174
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L. Dahut, William D. Figg, Nehal J. Lakhani et al.|Cancer Biology & Therapy|2006Cited by 155